BWX Technologies, Inc. $BWXT Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC decreased its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT) by 7.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,870 shares of the technology company’s stock after selling 14,604 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BWX Technologies were worth $39,981,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of BWXT. Aventura Private Wealth LLC purchased a new position in shares of BWX Technologies in the fourth quarter worth about $29,000. WFA of San Diego LLC purchased a new stake in BWX Technologies during the 2nd quarter valued at about $29,000. MV Capital Management Inc. purchased a new stake in BWX Technologies during the 4th quarter valued at about $32,000. Tucker Asset Management LLC acquired a new stake in BWX Technologies in the 4th quarter valued at about $36,000. Finally, ORG Partners LLC raised its holdings in BWX Technologies by 143.2% in the 4th quarter. ORG Partners LLC now owns 231 shares of the technology company’s stock valued at $40,000 after acquiring an additional 136 shares during the last quarter. 94.39% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the sale, the chief executive officer owned 202,491 shares in the company, valued at $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer directly owned 6,884 shares in the company, valued at approximately $1,440,477. This trade represents a 25.99% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by insiders.

BWX Technologies Stock Performance

BWX Technologies stock opened at $171.52 on Monday. The firm has a 50 day simple moving average of $194.86 and a 200-day simple moving average of $203.00. BWX Technologies, Inc. has a 1-year low of $136.18 and a 1-year high of $241.82. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. The stock has a market cap of $15.71 billion, a price-to-earnings ratio of 45.86, a price-to-earnings-growth ratio of 2.92 and a beta of 0.74.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. The business had revenue of $860.22 million during the quarter, compared to the consensus estimate of $837.47 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business’s revenue was up 26.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, analysts expect that BWX Technologies, Inc. will post 4.6 EPS for the current year.

BWX Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Tuesday, May 19th. This represents a $1.08 annualized dividend and a yield of 0.6%. BWX Technologies’s dividend payout ratio (DPR) is 28.88%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on BWXT. Zacks Research lowered shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Wells Fargo & Company initiated coverage on BWX Technologies in a report on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price target for the company. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a report on Monday, June 22nd. Truist Financial lifted their price objective on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Finally, Bank of America upped their target price on BWX Technologies from $230.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, March 25th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, BWX Technologies has an average rating of “Moderate Buy” and an average price target of $228.00.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.